nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—schizophrenia—Dimenhydrinate—atopic dermatitis	0.326	0.569	CpDpCtD
Paliperidone—schizophrenia—Diphenhydramine—atopic dermatitis	0.247	0.431	CpDpCtD
Paliperidone—HRH1—Dimenhydrinate—atopic dermatitis	0.0604	0.235	CbGbCtD
Paliperidone—HRH1—Diphenhydramine—atopic dermatitis	0.0295	0.115	CbGbCtD
Paliperidone—HRH1—Loratadine—atopic dermatitis	0.0295	0.115	CbGbCtD
Paliperidone—CYP3A5—Tacrolimus—atopic dermatitis	0.0262	0.102	CbGbCtD
Paliperidone—CYP3A4—Pimecrolimus—atopic dermatitis	0.0172	0.0669	CbGbCtD
Paliperidone—CYP2D6—Loratadine—atopic dermatitis	0.0118	0.0458	CbGbCtD
Paliperidone—CYP2D6—Diphenhydramine—atopic dermatitis	0.0118	0.0458	CbGbCtD
Paliperidone—CYP3A5—Hydrocortisone—atopic dermatitis	0.0107	0.0415	CbGbCtD
Paliperidone—CYP3A4—Tacrolimus—atopic dermatitis	0.0102	0.0398	CbGbCtD
Paliperidone—CYP3A4—Loratadine—atopic dermatitis	0.00749	0.0291	CbGbCtD
Paliperidone—CYP3A4—Methylprednisolone—atopic dermatitis	0.00685	0.0266	CbGbCtD
Paliperidone—CYP3A5—Dexamethasone—atopic dermatitis	0.00664	0.0258	CbGbCtD
Paliperidone—CYP3A4—Triamcinolone—atopic dermatitis	0.00519	0.0202	CbGbCtD
Paliperidone—CYP3A4—Betamethasone—atopic dermatitis	0.00445	0.0173	CbGbCtD
Paliperidone—CYP3A4—Prednisolone—atopic dermatitis	0.00439	0.0171	CbGbCtD
Paliperidone—CYP3A4—Hydrocortisone—atopic dermatitis	0.00417	0.0162	CbGbCtD
Paliperidone—CYP3A4—Prednisone—atopic dermatitis	0.00415	0.0161	CbGbCtD
Paliperidone—CYP2D6—Dexamethasone—atopic dermatitis	0.00407	0.0158	CbGbCtD
Paliperidone—CYP3A4—Dexamethasone—atopic dermatitis	0.00259	0.0101	CbGbCtD
Paliperidone—Dermatitis—Tacrolimus—atopic dermatitis	4.83e-05	0.000369	CcSEcCtD
Paliperidone—Shock—Prednisolone—atopic dermatitis	4.82e-05	0.000368	CcSEcCtD
Paliperidone—Cough—Triamcinolone—atopic dermatitis	4.81e-05	0.000368	CcSEcCtD
Paliperidone—Headache—Tacrolimus—atopic dermatitis	4.8e-05	0.000367	CcSEcCtD
Paliperidone—Anaphylactic shock—Hydrocortisone—atopic dermatitis	4.78e-05	0.000365	CcSEcCtD
Paliperidone—Oedema—Hydrocortisone—atopic dermatitis	4.78e-05	0.000365	CcSEcCtD
Paliperidone—Convulsion—Triamcinolone—atopic dermatitis	4.78e-05	0.000365	CcSEcCtD
Paliperidone—Tachycardia—Prednisolone—atopic dermatitis	4.78e-05	0.000365	CcSEcCtD
Paliperidone—Convulsion—Methylprednisolone—atopic dermatitis	4.77e-05	0.000364	CcSEcCtD
Paliperidone—Hypertension—Triamcinolone—atopic dermatitis	4.76e-05	0.000364	CcSEcCtD
Paliperidone—Hypertension—Methylprednisolone—atopic dermatitis	4.75e-05	0.000363	CcSEcCtD
Paliperidone—Infection—Hydrocortisone—atopic dermatitis	4.75e-05	0.000363	CcSEcCtD
Paliperidone—Shock—Hydrocortisone—atopic dermatitis	4.7e-05	0.000359	CcSEcCtD
Paliperidone—Myalgia—Triamcinolone—atopic dermatitis	4.7e-05	0.000359	CcSEcCtD
Paliperidone—Nervous system disorder—Hydrocortisone—atopic dermatitis	4.69e-05	0.000358	CcSEcCtD
Paliperidone—Myalgia—Methylprednisolone—atopic dermatitis	4.68e-05	0.000358	CcSEcCtD
Paliperidone—Arthralgia—Methylprednisolone—atopic dermatitis	4.68e-05	0.000358	CcSEcCtD
Paliperidone—Eye disorder—Prednisone—atopic dermatitis	4.68e-05	0.000357	CcSEcCtD
Paliperidone—Anxiety—Methylprednisolone—atopic dermatitis	4.67e-05	0.000357	CcSEcCtD
Paliperidone—Tachycardia—Hydrocortisone—atopic dermatitis	4.67e-05	0.000356	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	4.65e-05	0.000355	CcSEcCtD
Paliperidone—Flushing—Prednisone—atopic dermatitis	4.65e-05	0.000355	CcSEcCtD
Paliperidone—Skin disorder—Hydrocortisone—atopic dermatitis	4.64e-05	0.000355	CcSEcCtD
Paliperidone—Ill-defined disorder—Betamethasone—atopic dermatitis	4.64e-05	0.000355	CcSEcCtD
Paliperidone—Ill-defined disorder—Dexamethasone—atopic dermatitis	4.64e-05	0.000355	CcSEcCtD
Paliperidone—Discomfort—Triamcinolone—atopic dermatitis	4.64e-05	0.000354	CcSEcCtD
Paliperidone—Discomfort—Methylprednisolone—atopic dermatitis	4.63e-05	0.000354	CcSEcCtD
Paliperidone—Dry mouth—Triamcinolone—atopic dermatitis	4.59e-05	0.000351	CcSEcCtD
Paliperidone—Angioedema—Betamethasone—atopic dermatitis	4.57e-05	0.000349	CcSEcCtD
Paliperidone—Angioedema—Dexamethasone—atopic dermatitis	4.57e-05	0.000349	CcSEcCtD
Paliperidone—Anorexia—Hydrocortisone—atopic dermatitis	4.56e-05	0.000348	CcSEcCtD
Paliperidone—Nausea—Tacrolimus—atopic dermatitis	4.55e-05	0.000348	CcSEcCtD
Paliperidone—Angiopathy—Prednisone—atopic dermatitis	4.54e-05	0.000347	CcSEcCtD
Paliperidone—Confusional state—Methylprednisolone—atopic dermatitis	4.53e-05	0.000346	CcSEcCtD
Paliperidone—Immune system disorder—Prednisone—atopic dermatitis	4.52e-05	0.000345	CcSEcCtD
Paliperidone—Malaise—Dexamethasone—atopic dermatitis	4.51e-05	0.000345	CcSEcCtD
Paliperidone—Malaise—Betamethasone—atopic dermatitis	4.51e-05	0.000345	CcSEcCtD
Paliperidone—Anaphylactic shock—Triamcinolone—atopic dermatitis	4.5e-05	0.000344	CcSEcCtD
Paliperidone—Oedema—Triamcinolone—atopic dermatitis	4.5e-05	0.000344	CcSEcCtD
Paliperidone—Vertigo—Betamethasone—atopic dermatitis	4.5e-05	0.000343	CcSEcCtD
Paliperidone—Vertigo—Dexamethasone—atopic dermatitis	4.5e-05	0.000343	CcSEcCtD
Paliperidone—Anaphylactic shock—Methylprednisolone—atopic dermatitis	4.49e-05	0.000343	CcSEcCtD
Paliperidone—Syncope—Dexamethasone—atopic dermatitis	4.49e-05	0.000343	CcSEcCtD
Paliperidone—Syncope—Betamethasone—atopic dermatitis	4.49e-05	0.000343	CcSEcCtD
Paliperidone—Infection—Triamcinolone—atopic dermatitis	4.47e-05	0.000342	CcSEcCtD
Paliperidone—Hypotension—Hydrocortisone—atopic dermatitis	4.47e-05	0.000341	CcSEcCtD
Paliperidone—Infection—Methylprednisolone—atopic dermatitis	4.46e-05	0.000341	CcSEcCtD
Paliperidone—Shock—Triamcinolone—atopic dermatitis	4.43e-05	0.000338	CcSEcCtD
Paliperidone—Insomnia—Prednisolone—atopic dermatitis	4.43e-05	0.000338	CcSEcCtD
Paliperidone—Alopecia—Prednisone—atopic dermatitis	4.42e-05	0.000338	CcSEcCtD
Paliperidone—Shock—Methylprednisolone—atopic dermatitis	4.42e-05	0.000338	CcSEcCtD
Paliperidone—Nervous system disorder—Methylprednisolone—atopic dermatitis	4.4e-05	0.000336	CcSEcCtD
Paliperidone—Loss of consciousness—Betamethasone—atopic dermatitis	4.4e-05	0.000336	CcSEcCtD
Paliperidone—Loss of consciousness—Dexamethasone—atopic dermatitis	4.4e-05	0.000336	CcSEcCtD
Paliperidone—Paraesthesia—Prednisolone—atopic dermatitis	4.4e-05	0.000336	CcSEcCtD
Paliperidone—Tachycardia—Triamcinolone—atopic dermatitis	4.39e-05	0.000336	CcSEcCtD
Paliperidone—Mental disorder—Prednisone—atopic dermatitis	4.39e-05	0.000335	CcSEcCtD
Paliperidone—Tachycardia—Methylprednisolone—atopic dermatitis	4.38e-05	0.000335	CcSEcCtD
Paliperidone—Skin disorder—Methylprednisolone—atopic dermatitis	4.36e-05	0.000333	CcSEcCtD
Paliperidone—Malnutrition—Prednisone—atopic dermatitis	4.36e-05	0.000333	CcSEcCtD
Paliperidone—Erythema—Prednisone—atopic dermatitis	4.36e-05	0.000333	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	4.36e-05	0.000333	CcSEcCtD
Paliperidone—Convulsion—Dexamethasone—atopic dermatitis	4.34e-05	0.000331	CcSEcCtD
Paliperidone—Convulsion—Betamethasone—atopic dermatitis	4.34e-05	0.000331	CcSEcCtD
Paliperidone—Insomnia—Hydrocortisone—atopic dermatitis	4.32e-05	0.00033	CcSEcCtD
Paliperidone—Hypertension—Dexamethasone—atopic dermatitis	4.32e-05	0.00033	CcSEcCtD
Paliperidone—Hypertension—Betamethasone—atopic dermatitis	4.32e-05	0.00033	CcSEcCtD
Paliperidone—Paraesthesia—Hydrocortisone—atopic dermatitis	4.29e-05	0.000328	CcSEcCtD
Paliperidone—Myalgia—Betamethasone—atopic dermatitis	4.26e-05	0.000325	CcSEcCtD
Paliperidone—Myalgia—Dexamethasone—atopic dermatitis	4.26e-05	0.000325	CcSEcCtD
Paliperidone—Anxiety—Dexamethasone—atopic dermatitis	4.25e-05	0.000324	CcSEcCtD
Paliperidone—Anxiety—Betamethasone—atopic dermatitis	4.25e-05	0.000324	CcSEcCtD
Paliperidone—Discomfort—Betamethasone—atopic dermatitis	4.21e-05	0.000322	CcSEcCtD
Paliperidone—Discomfort—Dexamethasone—atopic dermatitis	4.21e-05	0.000322	CcSEcCtD
Paliperidone—Dyspepsia—Hydrocortisone—atopic dermatitis	4.21e-05	0.000321	CcSEcCtD
Paliperidone—Hypotension—Methylprednisolone—atopic dermatitis	4.2e-05	0.000321	CcSEcCtD
Paliperidone—Pain—Prednisolone—atopic dermatitis	4.19e-05	0.00032	CcSEcCtD
Paliperidone—Decreased appetite—Hydrocortisone—atopic dermatitis	4.16e-05	0.000317	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	4.13e-05	0.000315	CcSEcCtD
Paliperidone—Fatigue—Hydrocortisone—atopic dermatitis	4.12e-05	0.000315	CcSEcCtD
Paliperidone—Vision blurred—Prednisone—atopic dermatitis	4.11e-05	0.000314	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	4.1e-05	0.000313	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	4.09e-05	0.000313	CcSEcCtD
Paliperidone—Pain—Hydrocortisone—atopic dermatitis	4.09e-05	0.000312	CcSEcCtD
Paliperidone—Anaphylactic shock—Betamethasone—atopic dermatitis	4.08e-05	0.000312	CcSEcCtD
Paliperidone—Oedema—Betamethasone—atopic dermatitis	4.08e-05	0.000312	CcSEcCtD
Paliperidone—Anaphylactic shock—Dexamethasone—atopic dermatitis	4.08e-05	0.000312	CcSEcCtD
Paliperidone—Oedema—Dexamethasone—atopic dermatitis	4.08e-05	0.000312	CcSEcCtD
Paliperidone—Insomnia—Triamcinolone—atopic dermatitis	4.07e-05	0.000311	CcSEcCtD
Paliperidone—Insomnia—Methylprednisolone—atopic dermatitis	4.06e-05	0.00031	CcSEcCtD
Paliperidone—Infection—Betamethasone—atopic dermatitis	4.06e-05	0.00031	CcSEcCtD
Paliperidone—Infection—Dexamethasone—atopic dermatitis	4.06e-05	0.00031	CcSEcCtD
Paliperidone—Ill-defined disorder—Prednisone—atopic dermatitis	4.04e-05	0.000309	CcSEcCtD
Paliperidone—Paraesthesia—Triamcinolone—atopic dermatitis	4.04e-05	0.000309	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisolone—atopic dermatitis	4.03e-05	0.000308	CcSEcCtD
Paliperidone—Paraesthesia—Methylprednisolone—atopic dermatitis	4.03e-05	0.000308	CcSEcCtD
Paliperidone—Anaemia—Prednisone—atopic dermatitis	4.03e-05	0.000308	CcSEcCtD
Paliperidone—Shock—Dexamethasone—atopic dermatitis	4.02e-05	0.000307	CcSEcCtD
Paliperidone—Shock—Betamethasone—atopic dermatitis	4.02e-05	0.000307	CcSEcCtD
Paliperidone—Dyspnoea—Triamcinolone—atopic dermatitis	4.01e-05	0.000307	CcSEcCtD
Paliperidone—Nervous system disorder—Betamethasone—atopic dermatitis	4.01e-05	0.000306	CcSEcCtD
Paliperidone—Nervous system disorder—Dexamethasone—atopic dermatitis	4.01e-05	0.000306	CcSEcCtD
Paliperidone—Agitation—Prednisone—atopic dermatitis	4e-05	0.000306	CcSEcCtD
Paliperidone—Thrombocytopenia—Dexamethasone—atopic dermatitis	4e-05	0.000305	CcSEcCtD
Paliperidone—Thrombocytopenia—Betamethasone—atopic dermatitis	4e-05	0.000305	CcSEcCtD
Paliperidone—Tachycardia—Betamethasone—atopic dermatitis	3.99e-05	0.000304	CcSEcCtD
Paliperidone—Tachycardia—Dexamethasone—atopic dermatitis	3.99e-05	0.000304	CcSEcCtD
Paliperidone—Angioedema—Prednisone—atopic dermatitis	3.98e-05	0.000304	CcSEcCtD
Paliperidone—Dyspepsia—Triamcinolone—atopic dermatitis	3.96e-05	0.000303	CcSEcCtD
Paliperidone—Dyspepsia—Methylprednisolone—atopic dermatitis	3.95e-05	0.000302	CcSEcCtD
Paliperidone—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.94e-05	0.000301	CcSEcCtD
Paliperidone—Malaise—Prednisone—atopic dermatitis	3.93e-05	0.0003	CcSEcCtD
Paliperidone—Vertigo—Prednisone—atopic dermatitis	3.92e-05	0.000299	CcSEcCtD
Paliperidone—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.91e-05	0.000299	CcSEcCtD
Paliperidone—Syncope—Prednisone—atopic dermatitis	3.91e-05	0.000299	CcSEcCtD
Paliperidone—Anorexia—Betamethasone—atopic dermatitis	3.89e-05	0.000297	CcSEcCtD
Paliperidone—Anorexia—Dexamethasone—atopic dermatitis	3.89e-05	0.000297	CcSEcCtD
Paliperidone—Urticaria—Prednisolone—atopic dermatitis	3.89e-05	0.000297	CcSEcCtD
Paliperidone—Fatigue—Triamcinolone—atopic dermatitis	3.88e-05	0.000296	CcSEcCtD
Paliperidone—Fatigue—Methylprednisolone—atopic dermatitis	3.87e-05	0.000296	CcSEcCtD
Paliperidone—Pain—Triamcinolone—atopic dermatitis	3.85e-05	0.000294	CcSEcCtD
Paliperidone—Loss of consciousness—Prednisone—atopic dermatitis	3.83e-05	0.000293	CcSEcCtD
Paliperidone—Hypotension—Dexamethasone—atopic dermatitis	3.82e-05	0.000292	CcSEcCtD
Paliperidone—Hypotension—Betamethasone—atopic dermatitis	3.82e-05	0.000292	CcSEcCtD
Paliperidone—Urticaria—Hydrocortisone—atopic dermatitis	3.8e-05	0.00029	CcSEcCtD
Paliperidone—Abdominal pain—Hydrocortisone—atopic dermatitis	3.78e-05	0.000289	CcSEcCtD
Paliperidone—Body temperature increased—Hydrocortisone—atopic dermatitis	3.78e-05	0.000289	CcSEcCtD
Paliperidone—Convulsion—Prednisone—atopic dermatitis	3.78e-05	0.000288	CcSEcCtD
Paliperidone—Hypertension—Prednisone—atopic dermatitis	3.76e-05	0.000287	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.72e-05	0.000284	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.72e-05	0.000284	CcSEcCtD
Paliperidone—Myalgia—Prednisone—atopic dermatitis	3.71e-05	0.000283	CcSEcCtD
Paliperidone—Arthralgia—Prednisone—atopic dermatitis	3.71e-05	0.000283	CcSEcCtD
Paliperidone—Feeling abnormal—Triamcinolone—atopic dermatitis	3.71e-05	0.000283	CcSEcCtD
Paliperidone—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.7e-05	0.000283	CcSEcCtD
Paliperidone—Anxiety—Prednisone—atopic dermatitis	3.7e-05	0.000282	CcSEcCtD
Paliperidone—Insomnia—Dexamethasone—atopic dermatitis	3.69e-05	0.000282	CcSEcCtD
Paliperidone—Insomnia—Betamethasone—atopic dermatitis	3.69e-05	0.000282	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	3.68e-05	0.000281	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.67e-05	0.000281	CcSEcCtD
Paliperidone—Paraesthesia—Dexamethasone—atopic dermatitis	3.67e-05	0.00028	CcSEcCtD
Paliperidone—Paraesthesia—Betamethasone—atopic dermatitis	3.67e-05	0.00028	CcSEcCtD
Paliperidone—Discomfort—Prednisone—atopic dermatitis	3.67e-05	0.00028	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisolone—atopic dermatitis	3.61e-05	0.000275	CcSEcCtD
Paliperidone—Dyspepsia—Betamethasone—atopic dermatitis	3.6e-05	0.000275	CcSEcCtD
Paliperidone—Dyspepsia—Dexamethasone—atopic dermatitis	3.6e-05	0.000275	CcSEcCtD
Paliperidone—Urticaria—Triamcinolone—atopic dermatitis	3.58e-05	0.000273	CcSEcCtD
Paliperidone—Urticaria—Methylprednisolone—atopic dermatitis	3.57e-05	0.000273	CcSEcCtD
Paliperidone—Body temperature increased—Triamcinolone—atopic dermatitis	3.56e-05	0.000272	CcSEcCtD
Paliperidone—Anaphylactic shock—Prednisone—atopic dermatitis	3.56e-05	0.000272	CcSEcCtD
Paliperidone—Oedema—Prednisone—atopic dermatitis	3.56e-05	0.000272	CcSEcCtD
Paliperidone—Abdominal pain—Methylprednisolone—atopic dermatitis	3.55e-05	0.000271	CcSEcCtD
Paliperidone—Decreased appetite—Betamethasone—atopic dermatitis	3.55e-05	0.000271	CcSEcCtD
Paliperidone—Decreased appetite—Dexamethasone—atopic dermatitis	3.55e-05	0.000271	CcSEcCtD
Paliperidone—Infection—Prednisone—atopic dermatitis	3.53e-05	0.00027	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Betamethasone—atopic dermatitis	3.53e-05	0.000269	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	3.53e-05	0.000269	CcSEcCtD
Paliperidone—Hypersensitivity—Hydrocortisone—atopic dermatitis	3.52e-05	0.000269	CcSEcCtD
Paliperidone—Fatigue—Betamethasone—atopic dermatitis	3.52e-05	0.000269	CcSEcCtD
Paliperidone—Fatigue—Dexamethasone—atopic dermatitis	3.52e-05	0.000269	CcSEcCtD
Paliperidone—Shock—Prednisone—atopic dermatitis	3.5e-05	0.000267	CcSEcCtD
Paliperidone—Pain—Betamethasone—atopic dermatitis	3.49e-05	0.000267	CcSEcCtD
Paliperidone—Pain—Dexamethasone—atopic dermatitis	3.49e-05	0.000267	CcSEcCtD
Paliperidone—Nervous system disorder—Prednisone—atopic dermatitis	3.49e-05	0.000266	CcSEcCtD
Paliperidone—Tachycardia—Prednisone—atopic dermatitis	3.47e-05	0.000265	CcSEcCtD
Paliperidone—Skin disorder—Prednisone—atopic dermatitis	3.45e-05	0.000264	CcSEcCtD
Paliperidone—Asthenia—Hydrocortisone—atopic dermatitis	3.43e-05	0.000262	CcSEcCtD
Paliperidone—Anorexia—Prednisone—atopic dermatitis	3.39e-05	0.000259	CcSEcCtD
Paliperidone—Pruritus—Hydrocortisone—atopic dermatitis	3.38e-05	0.000258	CcSEcCtD
Paliperidone—Feeling abnormal—Dexamethasone—atopic dermatitis	3.37e-05	0.000257	CcSEcCtD
Paliperidone—Feeling abnormal—Betamethasone—atopic dermatitis	3.37e-05	0.000257	CcSEcCtD
Paliperidone—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.34e-05	0.000255	CcSEcCtD
Paliperidone—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.34e-05	0.000255	CcSEcCtD
Paliperidone—Hypersensitivity—Triamcinolone—atopic dermatitis	3.32e-05	0.000253	CcSEcCtD
Paliperidone—Hypersensitivity—Methylprednisolone—atopic dermatitis	3.31e-05	0.000253	CcSEcCtD
Paliperidone—Diarrhoea—Hydrocortisone—atopic dermatitis	3.27e-05	0.00025	CcSEcCtD
Paliperidone—Urticaria—Dexamethasone—atopic dermatitis	3.24e-05	0.000248	CcSEcCtD
Paliperidone—Urticaria—Betamethasone—atopic dermatitis	3.24e-05	0.000248	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Prednisone—atopic dermatitis	3.24e-05	0.000248	CcSEcCtD
Paliperidone—Dizziness—Prednisolone—atopic dermatitis	3.24e-05	0.000247	CcSEcCtD
Paliperidone—Asthenia—Triamcinolone—atopic dermatitis	3.23e-05	0.000247	CcSEcCtD
Paliperidone—Abdominal pain—Dexamethasone—atopic dermatitis	3.23e-05	0.000247	CcSEcCtD
Paliperidone—Abdominal pain—Betamethasone—atopic dermatitis	3.23e-05	0.000247	CcSEcCtD
Paliperidone—Body temperature increased—Betamethasone—atopic dermatitis	3.23e-05	0.000247	CcSEcCtD
Paliperidone—Body temperature increased—Dexamethasone—atopic dermatitis	3.23e-05	0.000247	CcSEcCtD
Paliperidone—Asthenia—Methylprednisolone—atopic dermatitis	3.22e-05	0.000246	CcSEcCtD
Paliperidone—Insomnia—Prednisone—atopic dermatitis	3.22e-05	0.000246	CcSEcCtD
Paliperidone—Paraesthesia—Prednisone—atopic dermatitis	3.19e-05	0.000244	CcSEcCtD
Paliperidone—Pruritus—Triamcinolone—atopic dermatitis	3.18e-05	0.000243	CcSEcCtD
Paliperidone—Pruritus—Methylprednisolone—atopic dermatitis	3.18e-05	0.000243	CcSEcCtD
Paliperidone—Dizziness—Hydrocortisone—atopic dermatitis	3.16e-05	0.000241	CcSEcCtD
Paliperidone—Dyspepsia—Prednisone—atopic dermatitis	3.13e-05	0.000239	CcSEcCtD
Paliperidone—Decreased appetite—Prednisone—atopic dermatitis	3.09e-05	0.000236	CcSEcCtD
Paliperidone—Rash—Prednisolone—atopic dermatitis	3.09e-05	0.000236	CcSEcCtD
Paliperidone—Dermatitis—Prednisolone—atopic dermatitis	3.08e-05	0.000236	CcSEcCtD
Paliperidone—Diarrhoea—Methylprednisolone—atopic dermatitis	3.07e-05	0.000235	CcSEcCtD
Paliperidone—Fatigue—Prednisone—atopic dermatitis	3.07e-05	0.000234	CcSEcCtD
Paliperidone—Headache—Prednisolone—atopic dermatitis	3.07e-05	0.000234	CcSEcCtD
Paliperidone—Constipation—Prednisone—atopic dermatitis	3.04e-05	0.000232	CcSEcCtD
Paliperidone—Vomiting—Hydrocortisone—atopic dermatitis	3.04e-05	0.000232	CcSEcCtD
Paliperidone—Rash—Hydrocortisone—atopic dermatitis	3.01e-05	0.00023	CcSEcCtD
Paliperidone—Dermatitis—Hydrocortisone—atopic dermatitis	3.01e-05	0.00023	CcSEcCtD
Paliperidone—Headache—Hydrocortisone—atopic dermatitis	2.99e-05	0.000229	CcSEcCtD
Paliperidone—Dizziness—Triamcinolone—atopic dermatitis	2.98e-05	0.000227	CcSEcCtD
Paliperidone—Dizziness—Methylprednisolone—atopic dermatitis	2.97e-05	0.000227	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisone—atopic dermatitis	2.93e-05	0.000224	CcSEcCtD
Paliperidone—Asthenia—Dexamethasone—atopic dermatitis	2.93e-05	0.000224	CcSEcCtD
Paliperidone—Asthenia—Betamethasone—atopic dermatitis	2.93e-05	0.000224	CcSEcCtD
Paliperidone—Gastrointestinal pain—Prednisone—atopic dermatitis	2.91e-05	0.000222	CcSEcCtD
Paliperidone—Nausea—Prednisolone—atopic dermatitis	2.91e-05	0.000222	CcSEcCtD
Paliperidone—Pruritus—Dexamethasone—atopic dermatitis	2.89e-05	0.000221	CcSEcCtD
Paliperidone—Pruritus—Betamethasone—atopic dermatitis	2.89e-05	0.000221	CcSEcCtD
Paliperidone—Vomiting—Triamcinolone—atopic dermatitis	2.86e-05	0.000219	CcSEcCtD
Paliperidone—Vomiting—Methylprednisolone—atopic dermatitis	2.86e-05	0.000218	CcSEcCtD
Paliperidone—Nausea—Hydrocortisone—atopic dermatitis	2.84e-05	0.000217	CcSEcCtD
Paliperidone—Rash—Triamcinolone—atopic dermatitis	2.84e-05	0.000217	CcSEcCtD
Paliperidone—Dermatitis—Triamcinolone—atopic dermatitis	2.84e-05	0.000217	CcSEcCtD
Paliperidone—Rash—Methylprednisolone—atopic dermatitis	2.83e-05	0.000216	CcSEcCtD
Paliperidone—Dermatitis—Methylprednisolone—atopic dermatitis	2.83e-05	0.000216	CcSEcCtD
Paliperidone—Urticaria—Prednisone—atopic dermatitis	2.83e-05	0.000216	CcSEcCtD
Paliperidone—Headache—Triamcinolone—atopic dermatitis	2.82e-05	0.000215	CcSEcCtD
Paliperidone—Headache—Methylprednisolone—atopic dermatitis	2.81e-05	0.000215	CcSEcCtD
Paliperidone—Abdominal pain—Prednisone—atopic dermatitis	2.81e-05	0.000215	CcSEcCtD
Paliperidone—Body temperature increased—Prednisone—atopic dermatitis	2.81e-05	0.000215	CcSEcCtD
Paliperidone—Diarrhoea—Dexamethasone—atopic dermatitis	2.79e-05	0.000213	CcSEcCtD
Paliperidone—Diarrhoea—Betamethasone—atopic dermatitis	2.79e-05	0.000213	CcSEcCtD
Paliperidone—Dizziness—Betamethasone—atopic dermatitis	2.7e-05	0.000206	CcSEcCtD
Paliperidone—Dizziness—Dexamethasone—atopic dermatitis	2.7e-05	0.000206	CcSEcCtD
Paliperidone—Nausea—Triamcinolone—atopic dermatitis	2.67e-05	0.000204	CcSEcCtD
Paliperidone—Nausea—Methylprednisolone—atopic dermatitis	2.67e-05	0.000204	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisone—atopic dermatitis	2.62e-05	0.0002	CcSEcCtD
Paliperidone—Vomiting—Dexamethasone—atopic dermatitis	2.6e-05	0.000198	CcSEcCtD
Paliperidone—Vomiting—Betamethasone—atopic dermatitis	2.6e-05	0.000198	CcSEcCtD
Paliperidone—Rash—Dexamethasone—atopic dermatitis	2.58e-05	0.000197	CcSEcCtD
Paliperidone—Rash—Betamethasone—atopic dermatitis	2.58e-05	0.000197	CcSEcCtD
Paliperidone—Dermatitis—Dexamethasone—atopic dermatitis	2.57e-05	0.000197	CcSEcCtD
Paliperidone—Dermatitis—Betamethasone—atopic dermatitis	2.57e-05	0.000197	CcSEcCtD
Paliperidone—Headache—Betamethasone—atopic dermatitis	2.56e-05	0.000195	CcSEcCtD
Paliperidone—Headache—Dexamethasone—atopic dermatitis	2.56e-05	0.000195	CcSEcCtD
Paliperidone—Asthenia—Prednisone—atopic dermatitis	2.55e-05	0.000195	CcSEcCtD
Paliperidone—Pruritus—Prednisone—atopic dermatitis	2.52e-05	0.000192	CcSEcCtD
Paliperidone—Diarrhoea—Prednisone—atopic dermatitis	2.43e-05	0.000186	CcSEcCtD
Paliperidone—Nausea—Betamethasone—atopic dermatitis	2.43e-05	0.000185	CcSEcCtD
Paliperidone—Nausea—Dexamethasone—atopic dermatitis	2.43e-05	0.000185	CcSEcCtD
Paliperidone—Dizziness—Prednisone—atopic dermatitis	2.35e-05	0.00018	CcSEcCtD
Paliperidone—Vomiting—Prednisone—atopic dermatitis	2.26e-05	0.000173	CcSEcCtD
Paliperidone—Rash—Prednisone—atopic dermatitis	2.24e-05	0.000171	CcSEcCtD
Paliperidone—Dermatitis—Prednisone—atopic dermatitis	2.24e-05	0.000171	CcSEcCtD
Paliperidone—Headache—Prednisone—atopic dermatitis	2.23e-05	0.00017	CcSEcCtD
Paliperidone—Nausea—Prednisone—atopic dermatitis	2.11e-05	0.000161	CcSEcCtD
Paliperidone—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	9.83e-06	0.000254	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CXCR3—atopic dermatitis	9.83e-06	0.000254	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CXCR3—atopic dermatitis	9.67e-06	0.00025	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL5—atopic dermatitis	9.63e-06	0.000249	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	9.62e-06	0.000249	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL5—atopic dermatitis	9.58e-06	0.000248	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CXCL10—atopic dermatitis	9.55e-06	0.000247	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	9.47e-06	0.000245	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	9.46e-06	0.000245	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CXCL10—atopic dermatitis	9.42e-06	0.000244	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	9.42e-06	0.000244	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	9.4e-06	0.000243	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	9.33e-06	0.000241	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL5—atopic dermatitis	9.32e-06	0.000241	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	9.31e-06	0.000241	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CCR5—atopic dermatitis	9.29e-06	0.00024	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	9.28e-06	0.00024	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—CXCL8—atopic dermatitis	9.27e-06	0.00024	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	9.19e-06	0.000238	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL5—atopic dermatitis	9.17e-06	0.000237	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	9.13e-06	0.000236	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CCL5—atopic dermatitis	9.13e-06	0.000236	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	9.12e-06	0.000236	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TAC1—atopic dermatitis	9.09e-06	0.000235	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NPS—atopic dermatitis	9.09e-06	0.000235	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	9e-06	0.000233	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NPS—atopic dermatitis	8.95e-06	0.000232	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	8.95e-06	0.000232	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NPS—atopic dermatitis	8.93e-06	0.000231	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TAC1—atopic dermatitis	8.93e-06	0.000231	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	8.92e-06	0.000231	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—IL2—atopic dermatitis	8.86e-06	0.000229	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	8.77e-06	0.000227	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—NGF—atopic dermatitis	8.77e-06	0.000227	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	8.76e-06	0.000227	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	8.76e-06	0.000227	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	8.76e-06	0.000227	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	8.74e-06	0.000226	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—NGF—atopic dermatitis	8.59e-06	0.000222	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	8.59e-06	0.000222	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	8.55e-06	0.000221	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	8.54e-06	0.000221	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—IL2—atopic dermatitis	8.53e-06	0.000221	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CXCL10—atopic dermatitis	8.5e-06	0.00022	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	8.47e-06	0.000219	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—NGF—atopic dermatitis	8.45e-06	0.000219	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL5—atopic dermatitis	8.45e-06	0.000219	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—CXCL8—atopic dermatitis	8.42e-06	0.000218	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	8.36e-06	0.000216	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	8.35e-06	0.000216	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	8.34e-06	0.000216	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL5—atopic dermatitis	8.32e-06	0.000215	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL5—atopic dermatitis	8.3e-06	0.000215	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	8.23e-06	0.000213	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CCR5—atopic dermatitis	8.22e-06	0.000213	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CCL5—atopic dermatitis	8.22e-06	0.000213	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	8.21e-06	0.000212	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	8.17e-06	0.000212	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	8.17e-06	0.000211	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	8.14e-06	0.000211	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	8.14e-06	0.000211	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	8.14e-06	0.000211	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CCL5—atopic dermatitis	8.11e-06	0.00021	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL2—atopic dermatitis	8.04e-06	0.000208	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	7.98e-06	0.000207	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	7.97e-06	0.000206	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	7.94e-06	0.000206	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	7.87e-06	0.000204	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	7.82e-06	0.000202	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NGF—atopic dermatitis	7.61e-06	0.000197	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	7.58e-06	0.000196	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	7.57e-06	0.000196	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GLB1—atopic dermatitis	7.53e-06	0.000195	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NGF—atopic dermatitis	7.51e-06	0.000194	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	7.48e-06	0.000193	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	7.43e-06	0.000192	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CCR5—atopic dermatitis	7.4e-06	0.000192	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	7.32e-06	0.000189	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CCR5—atopic dermatitis	7.31e-06	0.000189	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL2—atopic dermatitis	7.24e-06	0.000187	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	7.24e-06	0.000187	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ADSL—atopic dermatitis	7.22e-06	0.000187	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	7.21e-06	0.000187	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.18e-06	0.000186	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL2—atopic dermatitis	7.14e-06	0.000185	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	7.14e-06	0.000185	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	7.1e-06	0.000184	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	7.09e-06	0.000184	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	7.09e-06	0.000183	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	7.08e-06	0.000183	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	7.07e-06	0.000183	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PPARA—atopic dermatitis	7.06e-06	0.000183	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	7.03e-06	0.000182	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	6.97e-06	0.00018	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	6.94e-06	0.00018	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	6.94e-06	0.00018	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	6.86e-06	0.000177	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	6.84e-06	0.000177	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	6.83e-06	0.000177	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	6.82e-06	0.000177	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	6.78e-06	0.000175	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	6.75e-06	0.000175	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	6.73e-06	0.000174	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	6.64e-06	0.000172	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	6.6e-06	0.000171	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NGF—atopic dermatitis	6.54e-06	0.000169	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	6.53e-06	0.000169	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	6.52e-06	0.000169	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NGF—atopic dermatitis	6.51e-06	0.000169	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	6.48e-06	0.000168	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	6.45e-06	0.000167	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	6.45e-06	0.000167	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	6.37e-06	0.000165	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	6.33e-06	0.000164	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	6.33e-06	0.000164	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	6.3e-06	0.000163	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	6.3e-06	0.000163	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	6.28e-06	0.000162	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	6.23e-06	0.000161	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	6.23e-06	0.000161	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	6.21e-06	0.000161	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCL5—atopic dermatitis	6.2e-06	0.000161	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	6.2e-06	0.00016	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	6.19e-06	0.00016	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	6.19e-06	0.00016	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	6.19e-06	0.00016	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	6.16e-06	0.000159	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	6.11e-06	0.000158	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCL5—atopic dermatitis	6.09e-06	0.000158	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	6.07e-06	0.000157	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	6.06e-06	0.000157	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	6.03e-06	0.000156	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	6.02e-06	0.000156	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	5.98e-06	0.000155	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	5.93e-06	0.000153	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	5.92e-06	0.000153	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	5.91e-06	0.000153	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	5.8e-06	0.00015	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NGF—atopic dermatitis	5.75e-06	0.000149	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PPARA—atopic dermatitis	5.74e-06	0.000148	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	5.72e-06	0.000148	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NGF—atopic dermatitis	5.65e-06	0.000146	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NGF—atopic dermatitis	5.64e-06	0.000146	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	5.64e-06	0.000146	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	5.63e-06	0.000146	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	5.62e-06	0.000145	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	5.59e-06	0.000145	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCR5—atopic dermatitis	5.59e-06	0.000145	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	5.55e-06	0.000144	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	5.54e-06	0.000143	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	5.51e-06	0.000143	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	5.5e-06	0.000142	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCR5—atopic dermatitis	5.49e-06	0.000142	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL2—atopic dermatitis	5.47e-06	0.000141	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	5.4e-06	0.00014	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	5.39e-06	0.000139	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	5.39e-06	0.000139	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	5.38e-06	0.000139	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	5.37e-06	0.000139	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL2—atopic dermatitis	5.37e-06	0.000139	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	5.27e-06	0.000136	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PPARA—atopic dermatitis	5.26e-06	0.000136	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	5.22e-06	0.000135	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	5.16e-06	0.000134	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	5.14e-06	0.000133	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	5.14e-06	0.000133	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	5.12e-06	0.000133	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	5.05e-06	0.000131	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	5e-06	0.00013	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	4.97e-06	0.000129	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL2—atopic dermatitis	4.93e-06	0.000128	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	4.91e-06	0.000127	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	4.89e-06	0.000127	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL2—atopic dermatitis	4.83e-06	0.000125	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	4.8e-06	0.000124	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL2—atopic dermatitis	4.75e-06	0.000123	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	4.74e-06	0.000123	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL6—atopic dermatitis	4.73e-06	0.000122	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	4.66e-06	0.000121	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	4.65e-06	0.00012	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	4.57e-06	0.000118	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	4.54e-06	0.000117	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	4.48e-06	0.000116	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	4.44e-06	0.000115	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	4.42e-06	0.000114	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	4.37e-06	0.000113	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL2—atopic dermatitis	4.28e-06	0.000111	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL6—atopic dermatitis	4.26e-06	0.00011	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	4.24e-06	0.00011	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL2—atopic dermatitis	4.22e-06	0.000109	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL6—atopic dermatitis	4.2e-06	0.000109	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	3.99e-06	0.000103	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	3.94e-06	0.000102	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	3.89e-06	0.000101	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	3.85e-06	9.96e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	3.83e-06	9.91e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	3.81e-06	9.86e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	3.79e-06	9.81e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARA—atopic dermatitis	3.74e-06	9.68e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	3.72e-06	9.64e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL2—atopic dermatitis	3.68e-06	9.52e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	3.67e-06	9.49e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	3.66e-06	9.47e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL2—atopic dermatitis	3.66e-06	9.47e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	3.64e-06	9.42e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	3.56e-06	9.21e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	3.54e-06	9.17e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	3.51e-06	9.08e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	3.5e-06	9.07e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	3.49e-06	9.02e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	3.39e-06	8.76e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	3.38e-06	8.75e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	3.37e-06	8.72e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	3.33e-06	8.61e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	3.32e-06	8.59e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	3.28e-06	8.48e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	3.26e-06	8.43e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL2—atopic dermatitis	3.23e-06	8.36e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	3.22e-06	8.35e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—atopic dermatitis	3.21e-06	8.32e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL2—atopic dermatitis	3.18e-06	8.22e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL2—atopic dermatitis	3.17e-06	8.21e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	3.16e-06	8.18e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—atopic dermatitis	3.16e-06	8.17e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	3.11e-06	8.05e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	3.1e-06	8.01e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	3.03e-06	7.83e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	2.97e-06	7.69e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	2.93e-06	7.57e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	2.92e-06	7.55e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—atopic dermatitis	2.9e-06	7.5e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	2.89e-06	7.48e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	2.88e-06	7.44e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	2.86e-06	7.41e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—atopic dermatitis	2.84e-06	7.35e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—atopic dermatitis	2.79e-06	7.23e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	2.66e-06	6.89e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—atopic dermatitis	2.51e-06	6.51e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—atopic dermatitis	2.48e-06	6.42e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.44e-06	6.33e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	2.24e-06	5.8e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—atopic dermatitis	2.16e-06	5.6e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—atopic dermatitis	2.15e-06	5.57e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	2.09e-06	5.41e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	2.06e-06	5.33e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—atopic dermatitis	1.9e-06	4.91e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—atopic dermatitis	1.87e-06	4.83e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—atopic dermatitis	1.86e-06	4.82e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	1.83e-06	4.73e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	1.7e-06	4.4e-05	CbGpPWpGaD
